Imperagen Raises £5M to Advance AI-Driven Enzyme Engineering
Manchester-based Imperagen has secured £5 million in seed funding to expand its AI-driven enzyme engineering platform. The company aims to accelerate R&D and scale operations, targeting applications across pharmaceuticals, life sciences, and sustainable chemicals.